Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
about
Short-Sighted Virus Evolution and a Germline Hypothesis for Chronic Viral Infections.Rhesus macaque IFITM3 gene polymorphisms and SIV infection.Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitnessThe Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block.Quantifying perinatal transmission of Hepatitis B viral quasispecies by tag linkage deep sequencing.Mechanisms of HIV-1 Control.The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.Virus-Host Gene Interactions Define HIV-1 Disease Progression.Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.Interferon-I: The Pièce de Résistance of HIV-1 Transmission?Control of HIV infection by IFN-α: implications for latency and a cure.Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins.Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?Identification of residues controlling restriction versus enhancing activities of IFITM proteins on the entry of human coronaviruses.Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses.Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane.Interferons and beyond: Induction of antiretroviral restriction factors.HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.A CRISPR screen for factors regulating SAMHD1 degradation identifies IFITMs as potent inhibitors of lentiviral particle delivery.Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K is Species-Specific.Evolution of HIV-1 within untreated individuals and at the population scale in UgandaHLA-C downregulation by HIV-1 adapts to host HLA genotypeThe Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor UsagemTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3IFITM proteins inhibit HIV-1 protein synthesis
P2860
Q30234948-4B456E01-C725-468F-9B60-10D767E00CBCQ30361340-32203910-52F0-4F71-9ED1-319779B93EABQ37612507-C0854805-61A8-408C-A31D-073B5A7664AEQ37707466-4CCBC3F2-0BB1-44E1-80FA-C12E7821E3A3Q38599096-2012BA92-4146-4301-97B2-643110EF36E7Q38688274-24B70E6F-5F76-44F3-B663-CAFD79B8590EQ39013830-5D6B29C7-23AF-4180-BAB1-F59185757C35Q39400038-FE8C77CB-8ADB-44B7-8094-DF6ED4569369Q39605419-73472301-FBF1-4CD4-ACFE-E6CCBF1D98C9Q40295797-834815A4-8FF9-47E4-8613-D8B740BC7B06Q41922021-EF1E1C14-28B9-454A-B573-29EC8CBED0ECQ41928655-4D5C0874-692A-4684-8EC1-D0C9879391D0Q46197224-95E74028-C65B-4F58-ACF1-F6DB0D3B0527Q47138132-BD99FC76-FC4D-41A8-82A1-BD8537D05F3AQ47146547-7835D7CB-ED57-460A-A5E8-FD722ABAC3A6Q47269172-E7AF2597-C6BE-46B6-999E-5569F495D630Q47286763-43761290-B7BF-4110-AD79-26858A765307Q47546996-FE0B60BB-A6D1-4D37-8811-58F93F87ED36Q47550785-EAC46B7B-F198-4500-87EF-FD3D01805082Q47552023-ACA9A943-EE8E-4961-A92E-214D77FE70F2Q47555873-36A9CF7F-88F0-4D93-BA0F-9A807793FCD2Q52430897-8B9876D8-F63F-464B-AB26-18F41EEFDF76Q53705746-4513568E-995D-412A-950D-ABFA9A594AE9Q54216802-5F616F77-308A-4A15-83D2-ECAC224846A2Q56797307-2F9C8E48-8326-4CBD-A2AE-D7CD5EEDEE94Q56909688-F9C9F733-8E54-4F1B-8912-4C1414DDAF46Q56967621-7E731A52-0DAA-4280-8054-B1AB01E325AAQ57292151-A032EF0B-E9AD-4B1A-BCCC-03B85CE19C04Q59126216-46002C99-15D5-40AE-9111-E574BD10E710
P2860
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
@en
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
@nl
type
label
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
@en
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
@nl
prefLabel
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
@en
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
@nl
P2093
P2860
P50
P1433
P1476
Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
@en
P2093
Karen Coss
Sarah Smith
Shilpa S Iyer
P2860
P304
P356
10.1016/J.CHOM.2016.08.006
P50
P577
2016-09-15T00:00:00Z